Dr Elliot Brown, PrimeVigilance Director, has completed his participation as a consortium member in pharmacovigilance research project ‘Monitoring Medicines’.

PrimeVigilance is pleased to share with you the news that Dr Elliot Brown, PrimeVigilance Director, has recently completed his participation as a consortium member in a 4 year pharmacovigilance research project ‘Monitoring Medicines’. The project, funded by the Seventh Framework Programme (FP-7) of the Research Directorate of the European Commission (EC), was coordinated by the WHO / Uppsala Monitoring Centre. Its four themes were:

  • Strengthening consumer reporting
  • Pharmacovigilance centres collecting problems related to inappropriate drug use
  • Better use of existing global pharmacovigilance data
  • Developing active and focussed pharmacovigilance systems.

Share this:




This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services